Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04431258
Title ABTL0812 in Combination With FOLFIRINOX for First-line Treatment of Metastatic Pancreatic Study (PanC-ASAP)
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Ability Pharmaceuticals SL
Indications

pancreatic ductal adenocarcinoma

pancreatic adenocarcinoma

pancreatic carcinoma

Therapies

ABTL0812 + Fluorouracil + Irinotecan + Oxaliplatin

Fluorouracil + Irinotecan + Oxaliplatin

Age Groups: senior | adult
Covered Countries USA | ESP


No variant requirements are available.